Brett A Schroeder
Overview
Explore the profile of Brett A Schroeder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lynch M, Al-Marayaty R, Obeidin F, Alexiev B, Chen E, Viveiros P, et al.
BMC Cancer
. 2024 Oct;
24(1):1336.
PMID: 39478506
Purpose: Targeted therapy development in soft tissue sarcoma (STS) has been burdened by the heterogeneity of this group of rare tumors. B7 homolog 3 protein (B7-H3) is a molecule in...
2.
Biery D, Turicek D, Diorio C, Schroeder B, Shah N
Mol Ther
. 2024 Mar;
32(9):2979-2983.
PMID: 38532629
With expansion of chimeric antigen receptor (CAR) T cell therapy and broader utilization of anti-cytokine directed therapeutics for toxicity mitigation, the routine assessment of cytokines may enhance understanding of toxicity...
3.
Schroeder B, Mandelson M, Picozzi V
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067292
Background: Both gemcitabine- and 5-fluorouracil (5-FU)-based chemotherapy regimens have demonstrated efficacy in metastatic pancreatic cancer (MPC). Alternating these regimens may reduce toxicity, slow resistant cancer biology emergence, and provide a...
4.
Fayzullina D, Yakushov S, Kantserova K, Belyaeva E, Aniskin D, Tsibulnikov S, et al.
Cancers (Basel)
. 2023 Nov;
15(21).
PMID: 37958399
Ewing sarcoma (ES) is one of the most frequent types of malignant tumors among children. The active metabolic state of ES cells presents a new potential target for therapeutic interventions....
5.
Naveed Ahmad J, Schroeder B, Yun J, Aboulafia D
Case Rep Oncol
. 2023 Nov;
16(1):1353-1361.
PMID: 37946745
Introduction: Bing-Neel syndrome (BNS) is a rare and heterogenous manifestation of Waldenström macroglobulinemia (WM) involving central nervous system (CNS) infiltration by malignant lymphoplasmacytic cells. Efforts to standardize diagnostic criteria have...
6.
Seo Y, Lu H, Black G, Smythe K, Yu Y, Hsu C, et al.
JAMA Oncol
. 2023 Oct;
9(12):1660-1668.
PMID: 37824131
Importance: Metastatic soft tissue sarcomas (STSs) have limited systemic therapy options, and immunomodulation has not yet meaningfully improved outcomes. Intratumoral (IT) injection of the toll-like receptor 4 (TLR4) agonist glycopyranosyl...
7.
Schroeder B, Thomas A
J Thorac Oncol
. 2023 Aug;
18(9):1114-1117.
PMID: 37599042
No abstract available.
8.
Tsibulnikov S, Fayzullina D, Karlina I, Schroeder B, Karpova O, Timashev P, et al.
Cancer Gene Ther
. 2023 Apr;
30(8):1066-1071.
PMID: 37037906
Ewing sarcoma (ES) is an aggressive malignant tumor, characterized by non-random chromosomal translocations that produce fusion genes. Fusion genes and fusion protein products are promising targets for gene therapy. Therapeutic...
9.
Belyaeva E, Loginova N, Schroeder B, Goldlust I, Acharya A, Kumar S, et al.
Biomed Pharmacother
. 2023 Apr;
162:114683.
PMID: 37031493
The balance between cell death and cell survival is a highly coordinated process by which cells break down and remove unnecessary or harmful materials in a controlled, highly regulated, and...
10.
Lynch M, Alexiev B, Schroeder B, Pollack S
Curr Treat Options Oncol
. 2022 Nov;
23(12):1861-1876.
PMID: 36380108
While no PD-1 inhibitor has been FDA approved for use in sarcoma or proven efficacious in a randomized trial, the use of single agent PD-1 inhibitors is standard-of-care and recommended...